- Home
- ELVN vs BH Comparison
ELVN vs BH Comparison
Compare ELVN & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | BH |
|---|---|---|
| Founded | 2016 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 931.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELVN | BH |
|---|---|---|
| Price | $21.00 | $308.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $41.20 | N/A |
| AVG Volume (30 Days) | ★ 486.5K | 106.3K |
| Earning Date | 11-12-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.91 |
| Revenue | N/A | ★ $386,507,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.05 | N/A |
| P/E Ratio | ★ N/A | $454.06 |
| Revenue Growth | N/A | ★ 6.87 |
| 52 Week Low | $13.30 | $195.05 |
| 52 Week High | $25.96 | $381.83 |
Technical Indicators
Market Signals| Indicator | ELVN | BH |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 44.71 |
| Support Level | $19.58 | $287.61 |
| Resistance Level | $22.14 | $306.88 |
| Average True Range (ATR) | 1.28 | 16.26 |
| MACD | -0.06 | 1.61 |
| Stochastic Oscillator | 41.37 | 73.81 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About BH Biglari Holdings Inc. Class B
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.